Our Story
A PRESENTATION ON THE CAUSES OF AD &
THE ZN TREATMENT THERAPY TO PREVENT IT

As Discovered & Developed By Dr. Michael D’Andrea


Ken D’Andrea - President
Today the Foundation Carries on Dr. D’Andrea’s Proprietary Triple Combination Treatment Therapy
Hi my name is Ken D’Andrea, and I’d like to tell you about the Zachriel Neurosciences. We created this Nonprofit in New Jersey following my brother’s life work discovering the main causes of Alzheimer’s and developing a successful treatment to stop or prevent it.
The very first time he was asked by a major pharmaceutical company to analyze the slides of Alzheimer’s diseased brains, he saw “the evidence” of what was destroying the neurons, the precursor to Alzheimer’s. As an expert in molecular biology, and at staining slides, he explained this feat was possible because he was free to see and study the slides without any preconceived notion from “industry experts” on what Alzheimer’s was “supposed” to look like.
We’ve included a video link in this presentation that explains what Dr. D’Andrea discovered are the main causes of Alzheimer’s, Dementia and Mild Cognitive Impairment. Mike believed the best way to treat these diseases was to treat the causes of the disease and not the symptoms. This included the need to Diagnose It Early, and to Treat It Early, before all the complications of dying neurons, inflammation, and eventual plaque formation caused.
For years he wrote books on what he had discovered, gave lectures, provided white papers to the industry experts to no avail. Finally, he took it upon himself to undertake a few studies focused on finding a way to stop or prevent what he recognized as the main causes of Alzheimer’s.
After completing 2 successful studies, he had the evidence he needed to know he was on the right track to stopping or preventing this deadly disease. He developed a Triple Combination Treatment Therapy to treat the main 3 causes of Alzheimer’s, Dementia and MCI. Sadly, not long after developing the treatment process needed for the proofs of his treatment process, my brother who exercised regularly as a former black belt and appeared to be in great physical shape, passed away suddenly and shockingly to all of us. However, he left us with the treatment formula. Please read over the attached presentation and watch our detailed video to learn more about the causes of Alzheimer’s and how we can work to stop it with your support.
We believe it’s the successful combination of our 3 designated medication categories outlined in this presentation that will treat and prevent the early causes of this disease from developing into Alzheimer’s, Dementia, and MCI. On behalf of Zachriel Neurosciences and my brother who dedicated much of his adult life to solving this elusive riddle, we thank you for your consideration and your support.
Our Mission
-
To provide a successful N-of-1 treatment process that will prevent, slow, stop, and or reverse the effects of Mild Cognitive Impairment and Early-Stage Alzheimer’s.
-
To provide relief for patients, their families, and their caregivers, from the bonds and chains this debilitating disease causes for millions of people.
-
Complete the Independent Human Treatment Therapy Test in order to test and confirm the efficacy that the treatment process works for people with MCI and Early-Stage Alzheimer’s.
-
Once the efficacy is confirmed by the independent lab, expand the treatment therapy to more medical locations and patients. This is opportunity would be made possible in real time, because the treatment therapy uses existing, FDA approved medications in a unique repurposed triple combination treatment therapy.
-
While the treatment expansion continued to occur using the unique three pill packs, ZNF would simultaneously pursue the development of a singular pill treatment for convenience and broader market appeal. This process would be separate from the triple combination expansion which uses FDA existing medications.
Dr. Michael D'Andrea (1958-2019)


To Prove its Efficacy and to Bring this Treatment to the Public.

